149 related articles for article (PubMed ID: 10959552)
1. Expression of hepatocyte growth factor and c-met in ulcerative colitis.
Kitamura S; Kondo S; Shinomura Y; Isozaki K; Kanayama S; Higashimoto Y; Minami T; Kiyohara T; Yasunaga Y; Ishikawa H; Ohtani T; Ishiguro S; Matsuzawa Y
Inflamm Res; 2000 Jul; 49(7):320-4. PubMed ID: 10959552
[TBL] [Abstract][Full Text] [Related]
2. Association of hepatocyte-derived growth factor receptor/caudal type homeobox 2 co-expression with mucosal regeneration in active ulcerative colitis.
Sipos F; Constantinovits M; Valcz G; Tulassay Z; Műzes G
World J Gastroenterol; 2015 Jul; 21(28):8569-79. PubMed ID: 26229399
[TBL] [Abstract][Full Text] [Related]
3. Functional expression of HGF and its receptor in human colorectal cancer.
Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K
Digestion; 2000; 61(4):237-46. PubMed ID: 10878450
[TBL] [Abstract][Full Text] [Related]
4. Neutrophilic HGF-MET Signalling Exacerbates Intestinal Inflammation.
Stakenborg M; Verstockt B; Meroni E; Goverse G; De Simone V; Verstockt S; Di Matteo M; Czarnewski P; Villablanca EJ; Ferrante M; Boeckxstaens GE; Mazzone M; Vermeire S; Matteoli G
J Crohns Colitis; 2020 Dec; 14(12):1748-1758. PubMed ID: 32556102
[TBL] [Abstract][Full Text] [Related]
5. Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome.
Kammula US; Kuntz EJ; Francone TD; Zeng Z; Shia J; Landmann RG; Paty PB; Weiser MR
Cancer Lett; 2007 Apr; 248(2):219-28. PubMed ID: 16945480
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of hepatocyte growth factor and its receptor c-Met in nasal polyps.
Rho HS; Lee SH; Lee HM; Lee SH; Jung HH; Choi J; Park MK; Kang SM
Arch Otolaryngol Head Neck Surg; 2006 Sep; 132(9):985-9. PubMed ID: 16982975
[TBL] [Abstract][Full Text] [Related]
7. Expression of the hepatocyte growth factor and c-Met in colon cancer: correlation with clinicopathological features and overall survival.
Liu Y; Li Q; Zhu L
Tumori; 2012; 98(1):105-12. PubMed ID: 22495710
[TBL] [Abstract][Full Text] [Related]
8. Persistence of gene expression changes in noninflamed and inflamed colonic mucosa in ulcerative colitis and their presence in colonic carcinoma.
Toiyama Y; Mizoguchi A; Kimura K; Araki T; Yoshiyama S; Sakaguchi K; Miki C; Kusunoki M
World J Gastroenterol; 2005 Sep; 11(33):5151-5. PubMed ID: 16127744
[TBL] [Abstract][Full Text] [Related]
9. Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma.
Kim CH; Moon SK; Bae JH; Lee JH; Han JH; Kim K; Choi EC
Acta Otolaryngol; 2006 Jan; 126(1):88-94. PubMed ID: 16308260
[TBL] [Abstract][Full Text] [Related]
10. Expression and localization of hepatocyte growth factor and its receptor c-Met in inverted papillomas.
Choi JH; Lee SH; Lee HM; Lee SH; Jung HH; Choi J; Lim HW; Lee SW; Kang SM
Acta Otolaryngol; 2006 Jul; 126(7):724-9. PubMed ID: 16803712
[TBL] [Abstract][Full Text] [Related]
11. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
[TBL] [Abstract][Full Text] [Related]
12. Decreased Toll-like receptor-5 (TLR-5) expression in the mucosa of ulcerative colitis patients.
Stanislawowski M; Wierzbicki PM; Golab A; Adrych K; Kartanowicz D; Wypych J; Godlewski J; Smoczynski M; Kmiec Z
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():71-5. PubMed ID: 20083854
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats.
Tahara Y; Ido A; Yamamoto S; Miyata Y; Uto H; Hori T; Hayashi K; Tsubouchi H
J Pharmacol Exp Ther; 2003 Oct; 307(1):146-51. PubMed ID: 12954797
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis.
Nagashima M; Hasegawa J; Kato K; Yamazaki J; Nishigai K; Ishiwata T; Asano G; Yoshino S
J Rheumatol; 2001 Aug; 28(8):1772-8. PubMed ID: 11508578
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.
Inoue H; Yokoyama F; Kita Y; Yoshiji H; Tsujimoto T; Deguchi A; Nakai S; Morishita A; Uchida N; Masaki T; Watanabe S; Kuriyama S
Int J Mol Med; 2006 May; 17(5):857-64. PubMed ID: 16596271
[TBL] [Abstract][Full Text] [Related]
17. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.
Kawaguchi Y; Harigai M; Hara M; Fukasawa C; Takagi K; Tanaka M; Tanaka E; Nishimagi E; Kamatani N
J Rheumatol; 2002 Sep; 29(9):1877-83. PubMed ID: 12233882
[TBL] [Abstract][Full Text] [Related]
18. Elevated insulin-like growth factor 1 receptor, hepatocyte growth factor receptor and telomerase protein expression in mild ulcerative colitis.
Sipos F; Galamb O; Herszényi L; Molnár B; Solymosi N; Zágoni T; Berczi L; Tulassay Z
Scand J Gastroenterol; 2008 Mar; 43(3):289-98. PubMed ID: 18938767
[TBL] [Abstract][Full Text] [Related]
19. X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling.
Takeuchi H; Kim J; Fujimoto A; Umetani N; Mori T; Bilchik A; Turner R; Tran A; Kuo C; Hoon DS
Clin Cancer Res; 2005 Nov; 11(21):7621-8. PubMed ID: 16278380
[TBL] [Abstract][Full Text] [Related]
20. Bax is downregulated in inflamed colonic mucosa of ulcerative colitis.
Iimura M; Nakamura T; Shinozaki S; Iizuka B; Inoue Y; Suzuki S; Hayashi N
Gut; 2000 Aug; 47(2):228-35. PubMed ID: 10896914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
